Who are Freedom Convoy protest leaders Tamara Lich and Chris Barber, found guilty on mischief charges?
On Wednesday a sentencing hearing began for Freedom Convoy protest leaders Tamara Lich and Chris Barber, after the two were found guilty of mischief. Here's what to know about them, and what happens next.
Article content
Who are Tamara Lich and Chris Barber?
Article content
Article content
Lich and Barber were key figures behind the convoy protest, sometimes referred to as the Freedom Convoy, that occupied downtown Ottawa for three weeks beginning in late January 2022. The protests followed the end of vaccine mandate exemptions for cross-border truckers. Protesters called for the repeal of all COVID-19 mandates and restrictions.
Both are from Saskatchewan. Lich had previously been involved with Canada's Yellow Vest protests in Medicine Hat, Alta., and elsewhere, and the United We Roll truckers convoy and protest in Ottawa in 2019, which was in favour of pipelines and against carbon taxes.
Barber is a trucker and owns his own company, CB Trucking Limited, based in Swift Current, Sask.
Article content
Article content
When were they arrested?
Article content
Article content
Lich and Barber were arrested in Ottawa on Feb. 17, 2022, shortly after the government of Justin Trudeau invoked the Emergencies Act for the first time ever, bringing an end to the protest. (Last year, a Federal Court judge ruled that the response was unconstitutional and unjustifiable.) The convoy was cleared out of Ottawa's downtown core in a three-day police operation that began on Feb. 18.
Article content
At first, Lich was charged with counselling to commit mischief, and Barber with counselling to commit mischief, counselling to disobey a court order, counselling to obstruct police, and mischief that interferes with the use and enjoyment of property.
Article content
However, a month after their arrest the Crown submitted a relaid information sheet from Ottawa police, and the two were jointly accused of mischief, counselling mischief, obstructing police, counselling to obstruct police, counselling intimidation, and intimidation by blocking and obstructing one or more highways.
Article content
Article content
Were they found guilty?
Article content
Article content
On April 3, 2025, Ontario Court Justice Heather Perkins-McVey found both Lich and Barber guilty of mischief because the court ruled they routinely encouraged people to join or remain at the protest, despite knowing the negative effects it was having on downtown residents and businesses.
Article content
Barber also was found guilty of counselling others to disobey a court order for telling people to ignore a judge's injunction directing convoy participants to stop honking their truck horns. (Lich was not charged with that offence.)
Article content
They were both acquitted of intimidation and counselling intimidation, with the judge noting that their repeated calls to remain peaceful meant there was no menace or violence intended. They were also acquitted of obstructing police and counselling to obstruct police.
Article content
The Crown is seeking a prison sentence of seven years for Lich and eight years for Barber. Two days have been set aside for the parties to present their sentencing submissions.
Article content
What did Pierre Poilievre say about this?
Article content
Conservative Leader Pierre Poilievre has posted and shared several posts on social media criticizing the Crown's sentencing proposals. In one post on X on Monday he said: 'Let's get this straight: while rampant violent offenders are released hours after their most recent charges & antisemitic rioters vandalize businesses, terrorize daycares & block traffic without consequences, the Crown wants 7 years prison time for the charge of mischief for Lich & Barber. How is this justice?'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
5 hours ago
Could U.S. tariffs drive up drug prices? Manitoba bioscience group says it's complicated, but possible
Medicine manufacturers across Canada are on edge with the looming threat of catastrophic tariffs on pharmaceutical exports to the U.S., experts say. Earlier this month, U.S. President Donald Trump threatened to impose tariffs as high as 200 per cent on pharmaceuticals exported to the United States. Howard Lutnick, Trump's secretary of commerce, said details about the pharmaceutical tariffs would come at the end of July. The uncertainty this created is starting to reveal itself as stock prices of major pharmaceutical manufacturing companies with operations in Canada — companies like Emergent Biosolutions and Bausch Health — have declined in recent days. If a 200 per cent tariff were to be put into place then I think [pharmaceutical manufacturers] would have to potentially reconsider whether it makes sense to manufacture in Canada, says Shawn Bugden, dean of the school of pharmacy at Memorial University. So what could the impact be in Canada? Given the tariff uncertainty, it's intensely complicated, says Bugden. According to government data, the pharmaceutical industry in Canada represents two per cent (new window) of global market share, and the manufacturing portion of it alone consists of an average of 35,000 jobs since 2019. Enlarge image (new window) Andrea Ladouceur, president and chief executive officer of the Bioscience Association of Manitoba, describes the pharmaceutical industry as the cornerstone of the province's economy. Photo: CBC / Justin Fraser In Manitoba, medicine is one of the leading industries, accounting for between 30-35 per cent of the medicine manufactured in Canada, seven per cent of the province's GDP, and roughly 14,000 jobs, according to Andrea Ladouceur, president of the Bioscience Association of Manitoba. The pharmaceutical industry is the cornerstone of the Manitoba economy, said Ladouceur. If being in Canada becomes unaffordable for them, these companies are connected to the global market and moving out of Canada is not off the table. The danger of these companies leaving is multifaceted. Not only would there be the major economic impact of a shrinking key industry, but we'd also lose the security of having some of the drug supply manufactured here in Canada, according to Bugden. The reliance on international trade for essential goods like medicines has proved risky in the past. During the COVID-19 pandemic, drug shortages (new window) in Canada were not uncommon. If pharmaceutical manufacturers move operations out of the country, it will likely make Canada even more reliant on global markets than they already are: with 70 per cent of drugs imported from foreign countries, 16 per cent of which is imported from the U.S., accounting for nearly $9 billion, according to Bugden. However, Budgen's main concern is that a sizable tariff, like the 200 per cent figure touted by Trump, would undermine Canada's price control mechanisms like the Patented Medicine Prices Review Board and the pan-Canadian Pharmaceutical Alliance — which he views as major assets to Canadians. The Patented Medicine Prices Review Board — established in 1987 but amended in 2019 — is meant to (new window) ensure that the prices of patented medicines sold in Canada are not excessive. The board reviews the price of drugs and medicine and conducts hearings which may result in orders to reduce prices to a non-excessive level, according to guidelines listed on their website. Shawn Bugden, dean of the school of pharmacy at Memorial University, says if Canadian pharmaceutical companies are hurt by tariffs on imports to the U.S., it could have an impact on the supply of some medicines in Canada. Photo: Submitted by Shawn Bugden Bugden says that as an unintended consequence, implementing such a substantial tariff would likely raise the cost of manufacturing drugs and medicine globally, in turn applying pressure on the review board to break their own rules and allow for higher-priced drugs. The Americans have been transparent, they say they have the highest drug prices in the world, we want to lower them, but we're not going to lower them, which is what they should do and they have the ability to do, we're instead going to try and make everybody else pay higher prices so that it allows our prices to go down, said Bugden. As things stand, many pharmaceutical companies are waiting to see what will happen. CBC News has reached out to several pharmaceutical companies in Manitoba, but none have wanted to comment given the uncertainty of the situation they're facing. Ladouceur says they're fearful that tariffs may force them to increase their prices. At the end of the day, any increase in cost will be passed on to the consumer, says Ladouceur. And so for these companies it is a very hard spot because they know it may put them out of reach for the consumer, and having medicines are key to having a healthy life and sometimes save a life, so they are really concerned their products will become unaffordable for those that need them most. Trump has said that there would be a period — a year, or a year and a half after a tariff would be imposed for companies to get their act together. In light of that, Bugden doesn't think the end consumer will be paying the price for at least a year. I don't think consumers need to worry about the prices changing tomorrow, said Bugden. Keep calm and carry on, don't think you need to run to the drug store and fill up your prescriptions. I'm confident in the institutions we have in Canada to do the best job possible to maintain pricing and accessibility for Canadians, said Bugden.
Global News
7 hours ago
- Global News
U.S. job market data shows weaker than expected results amid the trade war
U.S. employers added just 73,000 jobs last month and Labor Department revisions showed that hiring was much weaker than previously reported in May and June. The unemployment rate ticked up to 4.2 per cent. The deterioration in the job market is taking place with companies paralyzed by uncertainty over President Donald Trump's erratic trade policies. The Labor Department reported Friday that revisions shaved a stunning 258,000 jobs off May and June payrolls. The stock market tumbled on the news. The American job market is deteriorating — ever so slowly. It's not showing up as widespread layoffs. The unemployment rate is still low. It's subtler than that: New college graduates are struggling to break into the job market. The unemployment rate for college graduates 22 to 27 years old, reached 5.8 per cent in March, the highest, excluding the pandemic, since 2012, and far above the nationwide unemployment rate. Story continues below advertisement Many Americans are staying in their jobs, unwilling to start the job hunt, because they believe this is as good as it gets, and there is growing evidence that they're right: Few industries are actually hiring aggressively. The current situation is a sharp reversal from the hiring boom of just three years ago when desperate employers were handing out signing bonuses and introducing perks such as Fridays off, fertility benefits and even pet insurance to recruit and keep workers. 2:21 Trump vs. Powell: POTUS, Fed chair agree state of U.S. economy is strong, but disagree on interest rates When the Labor Department was expected to show that companies, government agencies and nonprofits collectively added 115,000 jobs last month, according to a survey of forecasters by the data firm FactSet. Get daily National news Get the day's top news, political, economic, and current affairs headlines, delivered to your inbox once a day. Sign up for daily National newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy That is not a bad number but its worse than last year, and even last month, when employers added 147,000 jobs. Employers added an average 130,000 jobs a month through June, down 23 per cent from last year's hiring and a whopping 68 per cent below the 2021-2023 average when the economy was bounding back from COVID-19 lockdowns. Story continues below advertisement Weighing on the job market are the lingering effects of higher interest rates that were used by the Federal Reserve to fight inflation; President Donald Trump's massive import taxes and the costs and uncertainty they are imposing on businesses; and an anticipated drop in foreign workers as the president's massive deportation plans move forward. 'The labor market is poised for a summer slowdown as businesses put hiring plans on hold but refrain from broad-based layoffs,' Gregory Daco, chief economist at EY-Parthenon wrote in a commentary this week. 'We see job growth slowing well below trend in the coming months.'' Still, most American workers enjoy an unusual level of job security. The unemployment rate is low at 4.1 per cent. The number of Americans applying for unemployment benefits — a proxy for layoffs — remains at healthy levels. But Adam Schickling, senior economist at Vanguard, cautions that 'a low unemployment rate and a muted pace of layoffs mask underlying weakness.'' In a commentary Tuesday, Schickling wrote that the health of the job market 'can be a matter of individual perspective…If you're a registered nurse, you may believe the job market's health to be excellent. The unemployment rate for experienced health care practitioners is currently below two per cent. If you're young and just entering the labor force or you're older and seeking to reenter it, prospects may seem bleak.'' Story continues below advertisement The rate of people quitting their jobs — a sign they're confident they can land something better — has fallen from the record heights of 2021 and 2022 and is now below where it stood before the pandemic. For one thing, hiring has become concentrated in a handful of industries. So far this year, for example, private U.S. employers have added 644,000 jobs. Of those, nearly 405,000 — or 63 per cent — were in just one of the Labor Department's industry categories: healthcare and social assistance, which spans everything from hospitals to daycare centers. As hiring has cooled over the past couple of years it's become harder for young people or those re-entering the workforce to find jobs, leading to longer job searches or spells of unemployment. The Labor Department said the number of discouraged workers, who believe no jobs are available for them, rose by 256,000 in June to 637,000. 'Historically, a decline in hiring has been accompanied by a swift rise in layoffs, a one-two punch that drives up the unemployment rate,' Schickling wrote in a commentary. 'Today's labor market is defying that pattern.'' One reason is that manufacturing companies, which tend to pull the trigger on layoffs quickly when economic conditions weaken, account for an ever-smaller share of American jobs. 'So there is simply less headcount to cut,'' he said. The bottom line: 'Firms are pulling back on hiring without shedding existing workers in significant numbers,'' Schickling said. 'The result is a labor market that is softening gradually, not collapsing.''
Toronto Star
8 hours ago
- Toronto Star
EU chief's texts to a pharma boss during pandemic were likely erased, the NYT reports
BRUSSELS (AP) — Text messages exchanged between European Commission President Ursula von der Leyen and a pharmaceutical boss during the COVID-19 pandemic were seen by her top adviser and have likely been destroyed, the New York Times reported Friday. Von der Leyen and Pfizer CEO Albert Bourla exchanged the messages as COVID-19 ravaged European communities from Portugal to Finland and the EU scrambled to buy millions of hard to find vaccines. She was under intense scrutiny to deliver.
